The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Top Cited Papers
- 19 June 2009
- journal article
- Published by Elsevier BV in Immunity
- Vol. 30 (6), 832-844
- https://doi.org/10.1016/j.immuni.2009.04.014
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTORProceedings of the National Academy of Sciences of the United States of America, 2008
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cellsThe Journal of Experimental Medicine, 2008
- Transcriptional regulation of Th17 cell differentiationSeminars in Immunology, 2007
- Th17: the third member of the effector T cell trilogyCurrent Opinion in Immunology, 2007
- Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cellsInternational Immunopharmacology, 2007
- Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenanceProceedings of the National Academy of Sciences of the United States of America, 2007
- Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17–producing T cell responsesNature Immunology, 2007
- Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLBlood, 2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006